February 15th 2025
At the Envision Summit 2025 in San Juan, Puerto Rico, Jessica Steen, OD, FAAO talked with glaucoma surgeons on the importance of comanaging patients throughout their lifetime.
January 22nd 2025
December 31st 2024
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
View More
CRU Eye Symposium
March 28-30, 2025
Register Now!
Eye Care Symposia in Los Angeles
April 25-26, 2025
Register Now!
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
19th Annual Controversies in Modern Eye Care
May 4, 2025
Register Now!
(CME Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(COPE Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (CME Track)
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (COPE Track)
View More
Collaborative Care Symposium
May 30-31, 2025
Register Now!
Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data
View More
Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy
View More
Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)
View More
Burst CME Plus™ - Unveiling Pharmacological Advances in nAMD & DME: From Durability to Applicability
View More
Blepharitis prevalence and management studied in recent surveys
August 1st 2009Recent surveys of patients and eye care specialists were undertaken to obtain information about the prevalence and management of blepharitis. Survey results together with clinical trial data highlight use of topical azithromycin.
Read More
The European Society of Cataract and Refractive Surgeons journeys to Barcelona for XXVII Congress
August 1st 2009The European Society of Cataract and Refractive Surgeons will hold its XXVII Congress from Saturday, Sept. 12, through Wednesday, Sept. 16, in this Spanish city located on the Mediterranean coast.
Read More
Association for Research in Vision and Ophthalmology meeting highlights new therapeutics
August 1st 2009The 2009 Association for Research in Vision and Ophthalmology annual meeting highlighted research on the latest therapeutics in retinal disease, dry eye, lid margin disease, ocular allergies, and other conditions.
Read More
Risk of visual symptoms postLASIK is not predicted by large preoperative pupil size
August 1st 2009A prospective study including 51 patients who underwent bilateral wavefront-guided LASIK for low to moderate myopia assessed visual symptoms at follow-up visits through 12 months after surgery. There was no evidence that large preoperative pupil size correlated with increased risk of unwanted postLASIK symptoms.
Read More
A recent article in the Journal of the American Medical Association, an editorial in American Family Physician, articles in the general media outlets, and an updated patient advisory statement from the American Society of Cataract and Refractive Surgery and the American Academy of Ophthalmology aim to further education primary care physicians and patients about the association between a patient's use of tamsulosin and complications or difficulty during cataract surgery.
Read More
Ophthalmology Knowledge Assessment Program: A rite of passage for residents
August 1st 2009One resident wonders, what does your Ophthalmology Knowledge Assessment Program score say to others about you as a resident? With the exception of applying to oculoplastics fellowships, in the global scheme of things, it may make no difference. On the other hand, some residents wished they had done better because they would have been thought of more positively within their program.
Read More
Learning disabilities not caused by vision problems, according to research
July 28th 2009No scientific evidence supports the view that subtle eye or visual problems cause learning disabilities, according to a revised policy statement on learning disabilities, dyslexia, and vision issued by the American Academy of Ophthalmology.
Read More
Specialty eyewear has never looked so good
June 15th 2009Terms such as quality, style, and value may not be typically associated with the specialty eyewear industry. Certain brands are crossing the divide and making an appearance in corporate and industrial settings to provide protection and aesthetics in one package.
Read More
Online eyeglass buys: A potential threat to dispensing ophthalmologists
June 15th 2009The emerging trend toward the purchase of eyeglasses online is a threat for dispensaries. Even if the trend were to take hold, not everyone will choose to purchase eyeglasses online. Plan how your practice will react.
Read More
Boys with intermittent exotropia more likely to develop mental illness
June 9th 2009Children with intermittent exotropia, especially boys, appear more likely to develop mental illness by young adulthood than children without strabismus, according to a report in the June issue of Archives of Ophthalmology
Read More
Four percent of older U.S. men have dry eye disease
June 9th 2009Dry eye disease is common among American men aged more than 50 years and its prevalence increases with age, high blood pressure, benign prostrate disease, and the use of antidepressants, according to a report in the June issue of Archives of Ophthalmology.
Read More
Study compares M-SICS, phaco in charity camp population
May 1st 2009To answer the question of whether quality - specifically, uncorrected vision, astigmatism, visual rehabilitation, and safety - is sacrificed when M-SICS is performed instead of phaco, Sanduk Ruit, MD, Geoffrey Tabin, MD, David F. Chang, MD, and colleagues conducted the first prospective, randomized trial of phaco versus M-SICS in a charity camp population.
Read More